Sartorius AG (0NIQ) Q4 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Sartorius Ag.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.336 Ladies and gentlemen, welcome to the Sartorius and Sartorius Stadium Biotech Conference 00:00:04.336 -- 00:00:08.801 Call and Live Webcast on the Preliminary Full Year 2023 Results. 00:00:08.801 -- 00:00:13.006 I'm Sascha, the Chorus Call Operator. I would like to remind you that all participants 00:00:13.006 -- 00:00:16.270 will be listening on remote and the conference is being recorded. 00:00:16.270 -- 00:00:18.933 The presentation will be followed by a Q&A session. 00:00:18.933 -- 00:00:23.278 You can register for questions at any time by pressing Star 1 on your telephone. 00:00:23.278 -- 00:00:26.182 For operator assistance, please press 4 and 0. 00:00:26.182 -- 00:00:30.068 The conference must not be recorded for publication or broadcast. 00:00:30.068 -- 00:00:32.470 At this time, it is my pleasure to hand over to Dr. 00:00:32.470 -- 00:00:36.212 Joachim Kreuzberg. Please go ahead. 00:00:36.475 -- 00:00:41.099 Thank you very much, and also welcome from our side here, and thank you for being available 00:00:41.099 -- 00:00:45.484 a little bit earlier than usually. So, therefore, good day, but also good morning, I 00:00:45.484 -- 00:00:50.889 guess, to some of you. So, let me start 00:00:50.889 -- 00:00:56.375 the presentation by walking you through the most important highlights of the year 2023, 00:00:56.375 -- 00:01:01.881 which really has been a year of transition in a very volatile life science industry 00:01:01.881 -- 00:01:07.809 where everybody has been impacted by several partially expected, partially unexpected 00:01:07.809 -- 00:01:09.431 developments. 00:01:09.431 -- 00:01:14.458 So, first of all, the preliminary results for the group and both divisions are 00:01:14.458 -- 00:01:19.084 well in line with the adjusted ...